e-learning
resources
Vienna 2012
Monday, 03.09.2012
Tuberculosis: clinical findings II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Drug interaction in tuberculosis treatment – The role of pharmacists
N. Cebron Lipovec, J. Toni, P. Svetina Sorli, M. Kosnik (Golnik, Slovenia)
Source:
Annual Congress 2012 - Tuberculosis: clinical findings II
Session:
Tuberculosis: clinical findings II
Session type:
Thematic Poster Session
Number:
2604
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Cebron Lipovec, J. Toni, P. Svetina Sorli, M. Kosnik (Golnik, Slovenia). Drug interaction in tuberculosis treatment – The role of pharmacists. Eur Respir J 2012; 40: Suppl. 56, 2604
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Cryptogenic organising pneumonia – clarithromycin treatment – factors influencing treatment results and relapses
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009
The results of drug resistance survey of MDR-strains on second line drugs obtains in national reference laboratory – " M.Nasta " Institute – Bucharest
Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2011
Clinical pattern of extrapulmonary tuberculosis (EPT) as observed at a teaching hospital in India – are we missing them?
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009
Adults without HIV infection hospitalised for tuberculosis – Clinical and drug sensitivity profiles
Source: Annual Congress 2011 - Management of tuberculosis
Year: 2011
Increasing adherence to TB treatment – Pilot intervention in two counties in Romania
Source: Annual Congress 2011 - Tuberculosis epidemiology and public health
Year: 2011
Documentation & accuracy of smoking status – An educational need?
Source: Annual Congress 2011 - Smoking cessation science and smoking-related disorders
Year: 2011
Asthma medication and antibiotics – Cause or effect?
Source: Annual Congress 2010 - Paediatric respiratory epidemiology: early origins of childhood asthma
Year: 2010
Oral glucocorticoid treatment of severe asthma – Current practice in the US
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010
Pro-vasopressin (copeptin) in patients with community-acquired pneumonia – influence of antibiotic pre-treatment; results from the German competence network CAPNETZ
Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Year: 2009
Patients‘ knowledge about inhalation therapy in pulmology – One year after intervention
Source: Annual Congress 2011 - Medical education
Year: 2011
Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India
Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Year: 2009
Improvement of TB endemia control – a witness of DOTS efficiency
Source: Annual Congress 2009 - Tuberculosis control
Year: 2009
Regional reference centre for multi-drug resistant tuberculosis – 11 months of activity
Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis
Year: 2010
Outcome of zinc & vit-A supplementation in the treatment
multidrug resistance
pulmonary tuberculosis patients
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
Smoking assessment & treatment in hospital: Are we providing ‘right care‘ and/or missing cannabis-smoking?
Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment
Year: 2011
Tuberculosis – is there anything different over a decade?
Source: Annual Congress 2009 - Socio-economic impact of tuberculosis
Year: 2009
Side effects at second line TB drugs – 2 years experience of multidrug-resistant tuberculosis department from Bucharest
Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Year: 2010
Airway resistances: R
aw
, sR
aw
, sR
eff
– Which is the best determinant of airway function?
Source: Annual Congress 2010 - Lung function from infancy to adulthood
Year: 2010
COPD in primary care – they can be taught?
Source: Annual Congress 2009 - Diagnostic strategies in primary respiratory care
Year: 2009
Diagnosing COPD and asthma in primary care in Israel – The challenge and the change
Source: Annual Congress 2011 - Integrated care and telehealth in primary care
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept